Two regulations were deliberated and enacted

March 31st, 2020 | by

On March 30th, the State Administration for Market Regulation issued the “Measures for the Administration of Drug Registration” and  “Measures for the Supervision of Pharmaceutical Productions,” which will come into effect on July 1st. The two “Measures” stipulate that drug registration and manufacturing should be strictly supervised to make sure the safety of drugs. Besides, the system of Marketing Authorization Holder (MAH) should be implemented comprehensively. Moreover, a drug safety assurance system should be established to manage the life cycle of drugs.

《药品注册管理办法》等两规章审议通过   7月1日起执行

来源:医药网  2020.03.31


Leave a Reply

Your email address will not be published. Required fields are marked *